Apyx investors have opportunity to lead apyx medical corporation securities fraud lawsuit

Los angeles , june 15, 2022 /prnewswire/ --  glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against apyx medical corporation ("apyx" or the "company") (nasdaq: apyx). class period: may 12, 2021 – march 11, 2022 lead plaintiff deadline: august 5, 2022 if you wish to serve as lead plaintiff of the apyx lawsuit, you can submit your contact information at www.glancylaw.com/cases/apyx-medical-corporation-1/.
APYX Ratings Summary
APYX Quant Ranking